WallStreetZenWallStreetZen
Analyst Ranking
Bottom 6%
#4464 out of 4705 analysts
Average Return
-5.93%
Win Rate
38%12 out of 32
Risk vs Reward
Poor
Good

Matt Hewitt's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Simulations Plus IncSLP
+142.31%$31.01$75.14
2020-01-06 -
2021-01-06
Buy
Avid Bioservices IncCDMO
+122.41%$4.64$10.32
2023-12-08 -
2024-10-11
Buy
Biolife Solutions IncBLFS
+103.30%$12.42$25.25
2023-08-10 -
2024-08-09
Buy
Ligand Pharmaceuticals IncLGND
+63.13%$80.55$131.40
2020-10-21 -
2021-10-20
Buy
Omniab IncOABI
+31.85%$3.83$5.05
2023-04-13 -
2024-04-12
Buy

Matt Hewitt Analyst Color

Get additional color on Matt Hewitt's coverage of popular stocks

Matt Hewitt's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Champions Oncology IncCSBR
1Buy$6.00+32.16%Upgrades
a month ago
Biolife Solutions IncBLFS
3Buy$30.00+32.74%Maintains
2 months ago
Ligand Pharmaceuticals IncLGND
2Buy$140.00+36.00%Maintains
3 months ago
Simulations Plus IncSLP
7Buy$56.00+79.26%Reiterates
3 months ago
Inotiv IncNOTV
3Buy$10.00+443.48%Maintains
5 months ago
Schrodinger IncSDGR
3Buy$30.00+69.78%Maintains
5 months ago
Agiliti IncAGTI
1Buy$23.00+128.86%Initiates Coverage On
9 months ago
Avid Bioservices IncCDMO
3Buy$16.00+55.04%Maintains
10 months ago
Maxcyte IncMXCT
1Buy$7.00+80.41%Initiates Coverage On
10 months ago
Repligen CorpRGEN
2Buy$200.00N/AMaintains
a year ago
Omniab IncOABI
1Buy$10.00N/AInitiates Coverage On
a year ago
Surgalign Holdings IncSRGAQ
2Hold$2.00N/AMaintains
2 years ago
Science 37 Holdings IncSNCE
1Buy$200.00N/AInitiates Coverage On
2 years ago
Cynergistek IncCTEK
1Hold$1.25N/ADowngrades
2 years ago
Teladoc Health IncTDOC
4Hold$30.00N/AMaintains
2 years ago
Ispecimen IncISPC
1Buy$400.00N/AInitiates Coverage On
3 years ago
Omnicell IncOMCL
1Buy$205.00N/AMaintains
3 years ago
Vocera Communications IncVCRA
1Buy$30.00N/AUpgrades
4 years ago
Apollo Endosurgery IncAPEN
1Buy$11.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.